The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 8, Pages 1678-1693
Publisher
Wiley
Online
2015-05-17
DOI
10.1016/j.molonc.2015.04.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
- (2014) Lourdes Cortes-Dericks et al. BMC CANCER
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- MiR-200c and HuR in ovarian cancer
- (2013) Silvia Prislei et al. BMC CANCER
- Epithelial-mesenchymal plasticity in carcinoma metastasis
- (2013) J. H. Tsai et al. GENES & DEVELOPMENT
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase
- (2013) Meng Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
- (2013) J. Fu et al. NEURO-ONCOLOGY
- Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells
- (2013) Anamaria Brozovic et al. PLoS One
- MicroRNAs: Novel mediators of resistance to microtubule-targeting agents
- (2012) Arun Kanakkanthara et al. CANCER TREATMENT REVIEWS
- Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
- (2012) D. M. Cittelly et al. MOLECULAR CANCER THERAPEUTICS
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stressed tumor cell, chemosensitized cancer
- (2011) Erik A C Wiemer NATURE MEDICINE
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- The role of the miR-200 family in epithelial-mesenchymal transition
- (2010) Perry S. Mongroo et al. CANCER BIOLOGY & THERAPY
- Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma
- (2010) K. Pennington et al. CURRENT CANCER DRUG TARGETS
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma
- (2010) María Ángeles Castilla et al. JOURNAL OF PATHOLOGY
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- v 3 Integrin-Mediated Drug Resistance in Human Laryngeal Carcinoma Cells Is Caused by Glutathione-Dependent Elimination of Drug-Induced Reactive Oxidative Species
- (2008) A. Brozovic et al. MOLECULAR PHARMACOLOGY
- HGF Increases Cisplatin Resistance via Down-Regulation of AIF in Lung Cancer Cells
- (2007) Jin-Tang Chen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More